US Broker Ratings

Eli Lilly (LLY) Stock Analysis: Leveraging a 20.41% Potential Upside Amid Robust Revenue Growth

Eli Lilly and Company (NYSE: LLY), a titan in the healthcare sector, has caught the eye of investors with a market capitalization of $896.13 billion. Known for its innovation in..

Elanco Animal Health (ELAN) Stock Report: A Healthcare Stock with Nearly 50% Upside Potential

Elanco Animal Health Incorporated (NYSE: ELAN) is a formidable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered in Indianapolis, Indiana, Elanco has carved..

Guardant Health, Inc. (GH) Stock Analysis: Exploring a 37.51% Upside Potential in Precision Oncology

Guardant Health, Inc. (NASDAQ: GH), a trailblazer in the precision oncology sector, has made waves with its innovative approach to cancer diagnostics. The company’s portfolio of cutting-edge tests, including the..

Regeneron Pharmaceuticals, Inc. (REGN)

⚠️ No article content returned.

..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring its 18.37% Potential Upside

Bio-Rad Laboratories, Inc. (NYSE: BIO) is a prominent player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $6.62 billion, this American company headquartered..

Merck & Company, Inc. (MRK) Stock Analysis: A Healthcare Giant with a Robust 3.05% Dividend Yield

Merck & Company, Inc. (NYSE: MRK) stands as a towering figure in the healthcare sector, delivering innovative solutions in pharmaceuticals and animal health. Its market cap of $275.09 billion underscores..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a Potential 42.40% Upside

AptarGroup, Inc. (NYSE: ATR), a prominent player in the Healthcare sector’s Medical Instruments & Supplies industry, presents a compelling investment case with a potential upside of 42.40%, according to analyst..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Biotech Innovator with 21.91% Potential Upside

Roivant Sciences Ltd. (NASDAQ: ROIV), a prominent player in the biotechnology sector, continues to capture the attention of investors with its innovative approach in the healthcare landscape. Based in London,..

The Ensign Group, Inc. (ENSG) Investor Outlook: Exploring a 24% Upside Potential

The Ensign Group, Inc. (NASDAQ: ENSG) stands out as a formidable player in the healthcare sector, specifically within the medical care facilities industry. With its vast network of skilled nursing,..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: High Growth Potential with 18.69% Upside

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is a prominent player in the biotechnology sector, focusing on innovative treatments for central nervous system (CNS) disorders. Headquartered in New York, this biopharmaceutical company..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Exploring a 55% Potential Upside Amid Robust Revenue Growth

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a burgeoning force in the biotechnology sector, has captured investor attention with its promising pipeline of treatments for genetic diseases and a notable potential upside..

Medtronic plc (MDT) Stock Analysis: Exploring a 41.83% Potential Upside Amidst Solid Dividend Yield

Medtronic plc (NYSE: MDT), a leading name in the healthcare sector, is piquing investor interest with an impressive potential upside of 41.83%. Known for its innovation in medical devices, Medtronic..

Genmab A/S (GMAB) Stock Analysis: A 41.47% Potential Upside in the Biotech Sector

Genmab A/S (GMAB), a prominent player in the biotechnology sector, has caught the attention of investors with its promising prospects. Based in Denmark, Genmab focuses on developing antibody-based products for..

GSK plc (GSK) Stock Analysis: Exploring a 16.10% Potential Upside with Robust Dividend Yield

Investors are continually eyeing opportunities in the healthcare sector, and GSK plc (GSK) emerges as a compelling option with its strong market presence and promising growth potential. With a substantial..

Penumbra, Inc. (PEN) Stock Analysis: A Strong Buy with a 12.73% Upside Potential

Penumbra, Inc. (PEN), a standout player in the healthcare sector, is making waves in the medical devices industry with its cutting-edge thrombectomy systems and embolization products. As a U.S.-based company,..

Boston Scientific Corporation (BSX): Investor Outlook with a 61.71% Potential Upside

Boston Scientific Corporation (NYSE: BSX) is a formidable player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $78.3 billion, this U.S.-based company has..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Navigating a 17.45% Potential Upside in the Healthcare Sector

Teva Pharmaceutical Industries (NYSE: TEVA) stands out in the drug manufacturing sector as a key player in both specialty and generic pharmaceuticals, with a market cap of $39.93 billion. As..

Encompass Health Corporation (EHC) Stock Analysis: Unpacking the 31.88% Potential Upside

Encompass Health Corporation (NYSE: EHC) is making waves in the healthcare sector, specifically within the medical care facilities industry. As a major player in inpatient rehabilitation, the company is poised..

Amgen Inc. (AMGN) Stock Analysis: Navigating a 7.94% Potential Upside Amid Strong Dividend Yield

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, continues to captivate investor attention with its robust portfolio in the drug manufacturing industry. With a market capitalization of $176.21..

Moderna, Inc. (MRNA): Navigating a Complex Landscape with Potential Growth in Biotechnology

Moderna, Inc. (NASDAQ: MRNA), a prominent player in the biotechnology sector, continues to draw investor attention despite facing a challenging financial landscape. With a market capitalization of $19.46 billion, Moderna..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds